The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia. [electronic resource]
Producer: 20151015Description: 91-9 p. digitalISSN:- 1592-8721
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Arthritis, Rheumatoid -- genetics
- Biomarkers -- analysis
- Clonal Evolution -- genetics
- Female
- Follow-Up Studies
- High-Throughput Nucleotide Sequencing -- methods
- Humans
- Killer Cells, Natural -- drug effects
- Leukemia, Large Granular Lymphocytic -- drug therapy
- Male
- Middle Aged
- Mutation -- genetics
- Neoplasm Staging
- Prognosis
- Receptors, Antigen, T-Cell, alpha-beta -- genetics
- STAT3 Transcription Factor -- genetics
- T-Lymphocytes -- drug effects
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.